JP2011511804A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511804A5
JP2011511804A5 JP2010546054A JP2010546054A JP2011511804A5 JP 2011511804 A5 JP2011511804 A5 JP 2011511804A5 JP 2010546054 A JP2010546054 A JP 2010546054A JP 2010546054 A JP2010546054 A JP 2010546054A JP 2011511804 A5 JP2011511804 A5 JP 2011511804A5
Authority
JP
Japan
Prior art keywords
ifnα
inducible
expression profile
marker expression
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010546054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011511804A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/033407 external-priority patent/WO2009100342A2/en
Publication of JP2011511804A publication Critical patent/JP2011511804A/ja
Publication of JP2011511804A5 publication Critical patent/JP2011511804A5/ja
Pending legal-status Critical Current

Links

JP2010546054A 2008-02-08 2009-02-06 疾患マーカーおよびその使用 Pending JP2011511804A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US696308P 2008-02-08 2008-02-08
PCT/US2009/033407 WO2009100342A2 (en) 2008-02-08 2009-02-06 Disease markers and uses thereof

Publications (2)

Publication Number Publication Date
JP2011511804A JP2011511804A (ja) 2011-04-14
JP2011511804A5 true JP2011511804A5 (enExample) 2012-03-15

Family

ID=40952717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010546054A Pending JP2011511804A (ja) 2008-02-08 2009-02-06 疾患マーカーおよびその使用

Country Status (12)

Country Link
US (1) US20110262928A1 (enExample)
EP (2) EP2848702A1 (enExample)
JP (1) JP2011511804A (enExample)
KR (1) KR20110005783A (enExample)
CN (1) CN101999001B (enExample)
AU (1) AU2009212216B2 (enExample)
BR (1) BRPI0908065A2 (enExample)
CA (1) CA2714410A1 (enExample)
ES (1) ES2529593T3 (enExample)
MX (1) MX2010008698A (enExample)
SG (1) SG188147A1 (enExample)
WO (1) WO2009100342A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2692784C (en) * 2007-07-12 2018-10-02 The Brigham And Women's Hospital, Inc. Compositions and methods for diagnosing and assessing inflammatory myopathies
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
US8785414B2 (en) * 2009-03-31 2014-07-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome
SMT201700063T1 (it) * 2009-09-03 2017-03-08 Medimmune Llc Diagnosi di interferoni di tipo 1
JPWO2011126105A1 (ja) * 2010-04-08 2013-07-11 啓之 吉富 免疫系の異常疾患または関節系の異常疾患への罹患またはこれらの病勢を判定するための検査方法
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
WO2013020926A1 (en) * 2011-08-11 2013-02-14 Febit Holding Gmbh Complex sets of mirnas as non-invasive biomarkers for psoriasis
ITRM20110685A1 (it) 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci
EP2653554A1 (en) * 2012-04-17 2013-10-23 Istituto Nazionale Di Genetica Molecolare-INGM Immune response biomarkers
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
EP3013985A4 (en) * 2013-06-28 2017-07-19 Acumen Research Laboratories Pte. Ltd. Sepsis biomarkers and uses thereof
EP4428251A3 (en) 2014-09-11 2024-12-18 Immunis.AI, Inc. Methods of detecting prostate cancer
JP6531306B2 (ja) * 2015-02-20 2019-06-19 一三 西野 炎症性筋疾患鑑別マーカー及びそれを用いた炎症性筋疾患と非炎症性筋疾患の鑑別方法
CN108379584B (zh) * 2018-04-12 2020-08-11 上海交复生物医药科技有限公司 RSAD2通过wnt通路影响肿瘤细胞替莫唑胺耐药性
WO2019210179A1 (en) * 2018-04-27 2019-10-31 Stemline Therapeutics, Inc. Methods of treating an autoimmune disease with a human interleukin-3 (il-3)-diphtheria toxin conjugate (dt-il3)
CN110085282A (zh) * 2019-04-23 2019-08-02 华中师范大学 核酸结构中核苷酸与核苷酸相互作用预测的方法
CN110108880A (zh) * 2019-05-30 2019-08-09 四川大学华西医院 Fez1自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
CN110161235B (zh) * 2019-06-26 2022-04-12 江苏省中医院 三种血清蛋白联合用于强直性脊柱炎诊断的用途
KR20220084305A (ko) * 2019-10-04 2022-06-21 더 리젠츠 오브 더 유니버시티 오브 미시간 건선의 치료에서 항-종양 괴사 인자 치료법에 대한 반응성을 결정하는 방법
CN111378742A (zh) * 2020-04-16 2020-07-07 嘉兴程瑞医药科技有限公司 microRNA生物标志物及其在制备自身免疫疾病检测试剂盒中的应用
CN113388677A (zh) * 2021-06-17 2021-09-14 河北医科大学第二医院 包括ifi44的干燥症诊断标志物组合
CN117554614A (zh) * 2022-09-23 2024-02-13 上海市第十人民医院 蛋白生物标志物dpp4在克罗恩病临床诊断中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8303165D0 (en) 1983-02-04 1983-03-09 Secher D S Monoclonal antibody
JPS60500864A (ja) 1983-02-04 1985-06-06 ワドリ、テクナラジズ、インコーパレイティド 近縁関係にあるが別個のタンパク質間に存在する共通決定基に対して特異的なハイブリド−マ抗体の製造および特性づけ
DE3306060A1 (de) 1983-02-22 1984-08-23 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung
ATE78262T1 (de) 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
US20070166281A1 (en) * 2004-08-21 2007-07-19 Kosak Kenneth M Chloroquine coupled antibodies and other proteins with methods for their synthesis
US7833795B2 (en) * 2004-08-24 2010-11-16 The Trustees Of The University Of Pennsylvania Assessment of cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors
US20070065844A1 (en) * 2005-06-08 2007-03-22 Massachusetts Institute Of Technology Solution-based methods for RNA expression profiling
ES2432026T3 (es) * 2005-08-05 2013-11-29 Genentech, Inc. Métodos y composiciones para detectar trastornos autoinmunes
WO2008070135A2 (en) 2006-12-06 2008-06-12 Medimmune, Llc. Methods of treating systemic lupus erythematosus

Similar Documents

Publication Publication Date Title
JP2010526107A5 (enExample)
JP2014519487A5 (enExample)
JP2013503642A5 (enExample)
HRP20170091T1 (hr) Dijagnostika interferona tip 1
JP2011509071A5 (enExample)
JP2008546390A5 (enExample)
WO2007133682A2 (en) 100% sequence identity detection methods for variable genomes
JP2010512315A5 (enExample)
JP2005511076A5 (enExample)
JP2019528081A5 (enExample)
JP2010527917A5 (enExample)
JP2009535036A5 (enExample)
JP2017514813A5 (enExample)
JP2011511804A (ja) 疾患マーカーおよびその使用
JP2019528285A5 (enExample)
Younossi et al. Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin
Ayegbusi et al. Virus genes and host correlates of pathology are markedly reduced during respiratory syncytial and influenza virus co-infection in BALB/c mice
Casanova et al. Hyporeactivity of alveolar macrophages and higher respiratory cell permissivity characterize DBA/2J mice infected by influenza A virus
Glineur et al. Novel pneumoviruses (PnVs): evolution and inflammatory pathology
WO2009141731A3 (en) The large form of human 2', 5'-oligoadenylate synthetase oas3 for preventing or treating infection with positive-sense single-stranded rna viruses
JP2017512204A5 (enExample)
CN102787161A (zh) 一种检测结核分枝杆菌方法及其专用引物
EP2062984A3 (de) Primer und Sonden zum Nachweis genitaler HPV-Genotypen
Soltanialvar et al. Genetic analysis of polymerase complex (PA, PB1 and PB2) genes of H9N2 avian influenza viruses from Iran (1999 to 2009)
Younossi et al. Gene expression profile associated with superimposed non‐alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C